OpenURL Connection Search

Select item for more details and to access through your institution.

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Published in:
2011
By:
- Muraro E;
- Martorelli D;
- Turchet E;
- Miolo G;
- Scalone S;
- Comaro E;
- Talamini R;
- Mastorci K;
- Lombardi D;
- Perin T;
- Carbone A;
- Veronesi A;
- Crivellari D;
- Dolcetti R;
- Muraro, Elena;
- Martorelli, Debora;
- Turchet, Elisa;
- Miolo, Gianmaria;
- Scalone, Simona;
- Comaro, Elisa
Publication type:
journal article
Improved Natural Killer cell activity and retained anti-tumor CD8<sup>+</sup> T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
Published in:
Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0567-0
By:
- Muraro, E.;
- Comaro, E.;
- Talamini, R.;
- Turchet, E.;
- Miolo, G.;
- Scalone, S.;
- Militello, L.;
- Lombardi, D.;
- Spazzapan, S.;
- Perin, T.;
- Massarut, S.;
- Crivellari, D.;
- Dolcetti, Riccardo;
- Martorelli, D.
Publication type:
Article
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
Published in:
2015
By:
- Muraro, E;
- Comaro, E;
- Talamini, R;
- Turchet, E;
- Miolo, G;
- Scalone, S;
- Militello, L;
- Lombardi, D;
- Spazzapan, S;
- Perin, T;
- Massarut, S;
- Crivellari, D;
- Dolcetti, Riccardo;
- Martorelli, D
Publication type:
journal article

Found: 3

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.

Improved Natural Killer cell activity and retained anti-tumor CD8<sup>+</sup> T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.